β-defensin 125 inhibitors are a class of chemical compounds that specifically target and inhibit the activity of the β-defensin 125 protein, a member of the defensin family. Defensins are small, cysteine-rich peptides produced by a wide variety of organisms, including humans, and play a key role in various biological processes, particularly in innate immunity. β-defensin 125, like other defensins, is characterized by its ability to form distinct secondary structures, including β-sheets stabilized by disulfide bridges between cysteine residues. These structures allow defensins to interact with specific biological membranes or proteins, thereby influencing cellular signaling and molecular interactions. Inhibitors of β-defensin 125 are designed to interrupt these interactions by binding to critical regions of the peptide, altering its function or preventing it from engaging with target molecules or cellular membranes. The inhibition of β-defensin 125 thus leads to a change in the biochemical pathways it typically modulates, which may include the regulation of certain gene expressions, protein-protein interactions, or membrane permeabilities.
At a molecular level, β-defensin 125 inhibitors must be carefully designed to recognize and bind selectively to the active sites or key structural motifs of β-defensin 125, without affecting other defensins or proteins that may share homologous structures. This specificity is crucial to avoiding unintended interference with other biological processes. The interaction between inhibitors and β-defensin 125 is often mediated through hydrogen bonding, van der Waals forces, or hydrophobic interactions, all of which stabilize the inhibitor-peptide complex. Structural studies, such as X-ray crystallography or NMR, are frequently employed to understand how these inhibitors interact at the atomic level, providing insights into their binding mechanisms and enhancing the ability to design more potent or selective inhibitors. The development of β-defensin 125 inhibitors continues to be an area of interest in understanding the broader biochemical roles of defensins and how their inhibition can reveal new aspects of their molecular function.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Dexamethasone downregulates pro-inflammatory cytokines which can decrease the induction of “defensin beta 125” expression in epithelial cells. | ||||||
Hydrocortisone | 50-23-7 | sc-300810 | 5 g | $102.00 | 6 | |
Hydrocortisone has anti-inflammatory properties that may suppress the local immune response, potentially reducing “defensin beta 125” expression. | ||||||
Tetracycline | 60-54-8 | sc-205858 sc-205858A sc-205858B sc-205858C sc-205858D | 10 g 25 g 100 g 500 g 1 kg | $63.00 $94.00 $270.00 $417.00 $634.00 | 6 | |
Tetracycline can modulate the host immune response, which may indirectly result in decreased expression of “defensin beta 125” in response to microbial stimuli. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits mTOR signaling which is involved in the regulation of innate immunity, potentially leading to decreased “defensin beta 125” expression. | ||||||
Cyclosporin A | 59865-13-3 | sc-3503 sc-3503-CW sc-3503A sc-3503B sc-3503C sc-3503D | 100 mg 100 mg 500 mg 10 g 25 g 100 g | $63.00 $92.00 $250.00 $485.00 $1035.00 $2141.00 | 69 | |
Cyclosporin A inhibits calcineurin, which could reduce the activation of NFAT, a transcription factor that may be involved in “defensin beta 125” expression. | ||||||
Aspirin | 50-78-2 | sc-202471 sc-202471A | 5 g 50 g | $20.00 $42.00 | 4 | |
Aspirin inhibits cyclooxygenase enzymes and may reduce inflammation-driven expression of “defensin beta 125” in epithelia. | ||||||
Prednisolone | 50-24-8 | sc-205815 sc-205815A | 1 g 5 g | $84.00 $253.00 | 2 | |
Prednisolone, a glucocorticoid, can diminish the inflammatory response, potentially lowering “defensin beta 125” expression levels. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate interferes with folate metabolism, which is essential for cell proliferation and could indirectly affect “defensin beta 125” expression. | ||||||
Sulfasalazine | 599-79-1 | sc-204312 sc-204312A sc-204312B sc-204312C | 1 g 2.5 g 5 g 10 g | $61.00 $77.00 $128.00 $209.00 | 8 | |
Sulfasalazine is known to modulate inflammatory pathways, potentially decreasing expression of inflammation-induced proteins like “defensin beta 125”. | ||||||
Azathioprine | 446-86-6 | sc-210853D sc-210853 sc-210853A sc-210853B sc-210853C | 500 mg 1 g 2 g 5 g 10 g | $203.00 $176.00 $349.00 $505.00 $704.00 | 1 | |
Azathioprine impacts purine synthesis and can suppress the immune system, which might reduce “defensin beta 125” expression. | ||||||